Modification of MHC anchor residues generates heteroclitic peptides that alter TCR binding and T cell recognition. 2010

David K Cole, and Emily S J Edwards, and Katherine K Wynn, and Mathew Clement, and John J Miles, and Kristin Ladell, and Julia Ekeruche, and Emma Gostick, and Katherine J Adams, and Ania Skowera, and Mark Peakman, and Linda Wooldridge, and David A Price, and Andrew K Sewell
Cardiff University School of Medicine, Heath Park, Cardiff, United Kingdom.

Improving T cell Ags by altering MHC anchor residues is a common strategy used to enhance peptide vaccines, but there has been little assessment of how such modifications affect TCR binding and T cell recognition. In this study, we use surface plasmon resonance and peptide-MHC tetramer binding at the cell surface to demonstrate that changes in primary peptide anchor residues can substantially and unpredictably alter TCR binding. We also demonstrate that the ability of TCRs to differentiate between natural and anchor-modified heteroclitic peptides distinguishes T cells that exhibit a strong preference for either type of Ag. Furthermore, we show that anchor-modified heteroclitic peptides prime T cells with different TCRs compared with those primed with natural Ag. Thus, vaccination with heteroclitic peptides may elicit T cells that exhibit suboptimal recognition of the intended natural Ag and, consequently, impaired functional attributes in vivo. Heteroclitic peptide-based immune interventions therefore require careful evaluation to ensure efficacy in the clinic.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011948 Receptors, Antigen, T-Cell Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains. Antigen Receptors, T-Cell,T-Cell Receptors,Receptors, T-Cell Antigen,T-Cell Antigen Receptor,T-Cell Receptor,Antigen Receptor, T-Cell,Antigen Receptors, T Cell,Receptor, T-Cell,Receptor, T-Cell Antigen,Receptors, T Cell Antigen,Receptors, T-Cell,T Cell Antigen Receptor,T Cell Receptor,T Cell Receptors,T-Cell Antigen Receptors
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic

Related Publications

David K Cole, and Emily S J Edwards, and Katherine K Wynn, and Mathew Clement, and John J Miles, and Kristin Ladell, and Julia Ekeruche, and Emma Gostick, and Katherine J Adams, and Ania Skowera, and Mark Peakman, and Linda Wooldridge, and David A Price, and Andrew K Sewell
February 2015, European journal of immunology,
David K Cole, and Emily S J Edwards, and Katherine K Wynn, and Mathew Clement, and John J Miles, and Kristin Ladell, and Julia Ekeruche, and Emma Gostick, and Katherine J Adams, and Ania Skowera, and Mark Peakman, and Linda Wooldridge, and David A Price, and Andrew K Sewell
February 2021, Journal of translational medicine,
David K Cole, and Emily S J Edwards, and Katherine K Wynn, and Mathew Clement, and John J Miles, and Kristin Ladell, and Julia Ekeruche, and Emma Gostick, and Katherine J Adams, and Ania Skowera, and Mark Peakman, and Linda Wooldridge, and David A Price, and Andrew K Sewell
December 1996, Molecular immunology,
David K Cole, and Emily S J Edwards, and Katherine K Wynn, and Mathew Clement, and John J Miles, and Kristin Ladell, and Julia Ekeruche, and Emma Gostick, and Katherine J Adams, and Ania Skowera, and Mark Peakman, and Linda Wooldridge, and David A Price, and Andrew K Sewell
July 2020, International journal of molecular sciences,
David K Cole, and Emily S J Edwards, and Katherine K Wynn, and Mathew Clement, and John J Miles, and Kristin Ladell, and Julia Ekeruche, and Emma Gostick, and Katherine J Adams, and Ania Skowera, and Mark Peakman, and Linda Wooldridge, and David A Price, and Andrew K Sewell
March 1992, Journal of immunology (Baltimore, Md. : 1950),
David K Cole, and Emily S J Edwards, and Katherine K Wynn, and Mathew Clement, and John J Miles, and Kristin Ladell, and Julia Ekeruche, and Emma Gostick, and Katherine J Adams, and Ania Skowera, and Mark Peakman, and Linda Wooldridge, and David A Price, and Andrew K Sewell
October 1993, Cellular immunology,
David K Cole, and Emily S J Edwards, and Katherine K Wynn, and Mathew Clement, and John J Miles, and Kristin Ladell, and Julia Ekeruche, and Emma Gostick, and Katherine J Adams, and Ania Skowera, and Mark Peakman, and Linda Wooldridge, and David A Price, and Andrew K Sewell
February 2005, Molecular immunology,
David K Cole, and Emily S J Edwards, and Katherine K Wynn, and Mathew Clement, and John J Miles, and Kristin Ladell, and Julia Ekeruche, and Emma Gostick, and Katherine J Adams, and Ania Skowera, and Mark Peakman, and Linda Wooldridge, and David A Price, and Andrew K Sewell
March 2007, Molecular immunology,
David K Cole, and Emily S J Edwards, and Katherine K Wynn, and Mathew Clement, and John J Miles, and Kristin Ladell, and Julia Ekeruche, and Emma Gostick, and Katherine J Adams, and Ania Skowera, and Mark Peakman, and Linda Wooldridge, and David A Price, and Andrew K Sewell
January 1989, Cold Spring Harbor symposia on quantitative biology,
David K Cole, and Emily S J Edwards, and Katherine K Wynn, and Mathew Clement, and John J Miles, and Kristin Ladell, and Julia Ekeruche, and Emma Gostick, and Katherine J Adams, and Ania Skowera, and Mark Peakman, and Linda Wooldridge, and David A Price, and Andrew K Sewell
August 2019, Molecular immunology,
Copied contents to your clipboard!